Cns Pharmaceuticals Inc (CNSP) Annual Balance Sheets

Annual · GAAP · USD millions
Access CNSP quarterly Balance Sheets →
Tracking balance sheet results across Cns Pharmaceuticals Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.20
Cash & Short-term Investments7.00
Deferred Offering Costs DE0.05
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.86
Total Current Assets8.10
Equipment/Property/Plant Net0.02
Prepaid Expense, Noncurrent, Total PR0.50
Other Assets, Noncurrent0.00
Total Assets8.62
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.77
Accrued Liabilities, Current AC0.00
Notes Payable, Current NO0.33
Other Liabilities, Current0.00
Total Current Liabilities4.10
Total Long-term Debt0.00
Total Liabilities4.10
Stockholders' Equity
Common Stock Value0.00
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock104.80
Retained Earnings / Accumulated Deficit-100.28
Other Equity0.00
Common Stockholder's Equity4.52
Total Stockholder's Equity4.52
Liabilities & Stockholder's Equity8.62
4 historic quarters locked

Sign in to unlock the full Cns Pharmaceuticals Inc balance sheet history.

About Cns Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-002550

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License